Rachel Humphrey - 11 Aug 2022 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Rachel Humphrey
Issuer symbol
PYXS
Transactions as of
11 Aug 2022
Net transactions value
$0
Form type
4
Filing time
15 Aug 2022, 17:44:18 UTC
Previous filing
21 Oct 2021
Next filing
28 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $0 +236,220 $0.000000 236,220 11 Aug 2022 Common Stock 236,220 $2.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in three equal annual installments from the grant date, subject to the reporting person's continued service through the applicable vesting date.